ECM stiffness, mechanotransduction, and cell cycling

ECM 硬度、力转导和细胞循环

基本信息

  • 批准号:
    10210426
  • 负责人:
  • 金额:
    $ 42.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

SUMMARY Mechanobiology--how cells and tissues sense and respond to mechanical influences--is a rapidly growing field of increasing importance to the understanding of physiology and fibrosis-associated pathologies including cancer, lung and liver fibrosis, and especially cardiovascular disease. This application studies how cells sense and respond to mechanical cues contained within the stiffness of the extracellular matrix (ECM). Mechanical information in the ECM is relayed through integrin-adhesions and Rho family GTPases, but how these early signaling events drive cell fate and function remains poorly understood. Unraveling these connections is a major challenge in the field. We are addressing this gap in understanding by examining how changes in ECM stiffness are transduced into the signaling events that control cell cycling. By combining molecular analyses with cell culture on deformable substrata (hydrogels), we recently showed that focal adhesion kinase (FAK), p130Cas, and Rac comprise a discrete signaling module that functions as a positive regulator of stiffness-sensitive cyclin D1 expression and cell cycling into S phase. But signaling in non- transformed cells is rarely linear and uni-directional: negative regulation commonly complements positive signaling to provide tight control of fate. These negative signals and pathways are often not well understood, and this is certainly the case for stiffness-regulated mechanotransduction. We therefore used RNASeq to search for ways that cells might limit stiffness-sensing to prevent over-stimulation. This analysis identified the long noncoding RNA, MALAT1, as a novel negative regulator of stiffness-dependent cell cycling: MALAT1 stimulates entry into S phase, but ECM stiffness reduces the expression level of MALAT1. Curiously, stiffness- stimulated Rac activity mediates both the induction of cyclin D1 and the repression of MALAT1. We now propose to examine the relationships between ECM stiffness, MALAT1 and cyclin D1, and their upstream activators. Aim 1 will examine the impact of MALAT1 on the G1 phase cyclin-cdks, assess crosstalk between MALAT1 and cyclin D1, and determine how changes in ECM composition and integrin display may affect rigidity-dependent regulation of MALAT1, cyclin D1 and cell cycling. Aim 2 looks upstream of cyclin D1 and MALAT1 and will determine how distinct components in the integrin-adhesion that share an ability to activate Rac can differentially regulate MALAT1. Finally, Aim 3 will test the relevance of our findings in vivo by analyzing smooth muscle cell proliferation in a mouse model of tissue stiffening and smooth muscle cell proliferation after vascular injury.
总结

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mechanosensitive smooth muscle cell phenotypic plasticity emerging from a null state and the balance between Rac and Rho.
  • DOI:
    10.1016/j.celrep.2021.109019
  • 发表时间:
    2021-04-20
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Talwar S;Kant A;Xu T;Shenoy VB;Assoian RK
  • 通讯作者:
    Assoian RK
Key role for Rac in the early transcriptional response to extracellular matrix stiffness and stiffness-dependent repression of ATF3.
  • DOI:
    10.1242/jcs.260636
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Dang, Irene;Brazzo, Joseph A.;Bae, Yongho;Assoian, Richard K.
  • 通讯作者:
    Assoian, Richard K.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Assoian其他文献

Richard Assoian的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Assoian', 18)}}的其他基金

Arterial stiffening and SMC mechanobiology in Hutchinson-Guilford Progeria Syndrome
哈钦森-吉尔福德早衰综合症中的动脉硬化和 SMC 力学生物学
  • 批准号:
    10368103
  • 财政年份:
    2019
  • 资助金额:
    $ 42.49万
  • 项目类别:
Arterial stiffening and SMC mechanobiology in Hutchinson-Guilford Progeria Syndrome
哈钦森-吉尔福德早衰综合症中的动脉硬化和 SMC 力学生物学
  • 批准号:
    10609809
  • 财政年份:
    2019
  • 资助金额:
    $ 42.49万
  • 项目类别:
Arterial stiffening and SMC mechanobiology in Hutchinson-Guilford Progeria Syndrome
哈钦森-吉尔福德早衰综合症中的动脉硬化和 SMC 力学生物学
  • 批准号:
    9816369
  • 财政年份:
    2019
  • 资助金额:
    $ 42.49万
  • 项目类别:
ECM stiffness, mechanotransduction, and cell cycling
ECM 硬度、力转导和细胞循环
  • 批准号:
    9978116
  • 财政年份:
    2018
  • 资助金额:
    $ 42.49万
  • 项目类别:
Aging, gender and arterial stiffness in atherosclerosis
动脉粥样硬化中的衰老、性别和动脉僵硬度
  • 批准号:
    8668406
  • 财政年份:
    2014
  • 资助金额:
    $ 42.49万
  • 项目类别:
apoE, arterial biomechanics, and cardiovascular disease
apoE、动脉生物力学和心血管疾病
  • 批准号:
    8919442
  • 财政年份:
    2014
  • 资助金额:
    $ 42.49万
  • 项目类别:
apoE, arterial biomechanics, and cardiovascular disease
apoE、动脉生物力学和心血管疾病
  • 批准号:
    8771694
  • 财政年份:
    2014
  • 资助金额:
    $ 42.49万
  • 项目类别:
apoE, arterial biomechanics, and cardiovascular disease
apoE、动脉生物力学和心血管疾病
  • 批准号:
    9081644
  • 财政年份:
    2014
  • 资助金额:
    $ 42.49万
  • 项目类别:
apoE, arterial biomechanics, and cardiovascular disease
apoE、动脉生物力学和心血管疾病
  • 批准号:
    9305135
  • 财政年份:
    2014
  • 资助金额:
    $ 42.49万
  • 项目类别:
Aging, gender and arterial stiffness in atherosclerosis
动脉粥样硬化中的衰老、性别和动脉僵硬度
  • 批准号:
    9268535
  • 财政年份:
    2014
  • 资助金额:
    $ 42.49万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.49万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了